Genital psoriasis is common. In this cohort, 43.2% of psoriasis patients had genital involvement. Genital psoriasis presents differently than it does elsewhere on the body. More discussion between ...
The evolution of genitourinary cancer treatment includes a shift from monotherapies to combination therapies, improving survival and quality of life. Combining androgen blockers with DNA repair ...
After a median follow-up of 9.9 months, 38% of the trial participants experienced some degree of tumor shrinkage after receiving Opdivo in combination with Yervoy. Combining Opdivo (nivolumab) and ...
Arcutis Biotherapeutics has published 14 consensus statements developed by the Genital Psoriasis Wellness Consortium, a group of experts aimed at improving the understanding and management of genital ...
Standardized Patients (SP) are "Individuals who are trained to present the symptoms and signs of disease process as they present in real patients" (Barrows, 1985). Standardized patients have been ...
Arcutis convened the Genital Psoriasis Wellness Consortium, a multidisciplinary group of clinicians who are experts in their fields Publication includes 14 consensus statements aimed at improving ...
In an online survey, 17.2% of patients with genitourinary cancers reported they delayed or avoided seeking medical care because of the COVID-19 pandemic. Preliminary survey findings presented at the ...
Genital psoriasis is common. In this cohort, 43.2% of psoriasis patients had genital involvement. Genital psoriasis presents differently than it does elsewhere on the body. More discussion between ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback